Thomas Wang Archives
Sep. 17, 2015—Three Vanderbilt University researchers on the cutting edge of discovery will discuss the “human determinants of cardiovascular disease and treatment” during the next Flexner Discovery Lecture on Sept. 24.
Feb. 19, 2015—Despite prior epidemiologic and experimental data to the contrary, new research shows that vitamin D supplementation does not reduce blood pressure in individuals with prehypertension or stage I hypertension and vitamin D deficiency.
Dec. 11, 2014—When it comes to taking care of our hearts, there is a big divide between what we should do and what we actually do, a new multi-institution study reports.
Nov. 6, 2014—Vanderbilt’s biobank, BioVU, has begun to collect and store plasma, the liquid part of blood, to aid studies of diseases ranging from heart failure and hypertension to breast cancer.
Jul. 10, 2014—Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
Sep. 17, 2013—Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.
Dec. 20, 2012—Doug Sawyer, M.D., Ph.D., Lisa M. Jacobson Chair of Cardiovascular Medicine and Professor of Medicine and Pharmacology, will step down as director of the Division of Cardiovascular Medicine and physician-in-chief of the Vanderbilt Heart and Vascular Institute (VHVI), effective April 1, 2013. Sawyer will continue to pursue his clinical, teaching and research endeavors at VHVI....